Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-13-002089
Filing Date
2013-01-11
Accepted
2013-01-11 16:50:09
Documents
128

Document Format Files

Seq Description Document Type Size
1 S-1/A a12-29890_1s1a.htm S-1/A 4230027
2 EX-23.1 a12-29890_1ex23d1.htm EX-23.1 3753
3 EX-23.2 a12-29890_1ex23d2.htm EX-23.2 3032
11 GRAPHIC g298901cwi001.gif GRAPHIC 2501
12 GRAPHIC g298901dai001.jpg GRAPHIC 2880
13 filename13.htm CORRESP 22216
  Complete submission text file 0001104659-13-002089.txt   24613738

Data Files

Seq Description Document Type Size
4 EX-101.INS cycc-20130115.xml EX-101.INS 2786320
5 EX-101.SCH cycc-20130115.xsd EX-101.SCH 112843
6 EX-101.CAL cycc-20130115_cal.xml EX-101.CAL 172008
7 EX-101.LAB cycc-20130115_lab.xml EX-101.LAB 1588964
8 EX-101.PRE cycc-20130115_pre.xml EX-101.PRE 1095877
9 EX-101.DEF cycc-20130115_def.xml EX-101.DEF 756688
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-185674 | Film No.: 13525909
SIC: 2834 Pharmaceutical Preparations